Latest News

The excitement of investing in a company that can reverse its fortunes is a big draw for some speculators, so even...

Coca-Cola Consolidated (COKE) just lined up a $1.35 billion loan agreement, a sizable financing move that should reshape its debt profile and give management more room to maneuver strategically. See our latest analysis for Coca-Cola Consolidated. The financing news lands after a strong run in the stock, with Coca-Cola Consolidated’s share price at $164.51 and a 30 day share price return of 19.40 percent, backed by a powerful 5 year total shareholder return of 554.40 percent that suggests...

It is hard to get excited after looking at Australian Premium Solar (India)'s (NSE:APS) recent performance, when its...

Sika (SWX:SIKA) just pulled back the curtain on its Fast Forward program, a multi year push to digitize its value chain, streamline operations, and reshape its footprint, especially in China. See our latest analysis for Sika. The Fast Forward announcement lands after a tough stretch, with the share price down sharply on a year to date basis and the one year total shareholder return also deeply negative. This suggests sentiment has cooled even as management signals a profitability reset. If...

Catalyst Pharmaceuticals (CPRX) just delivered an upside third quarter, as strong Firdapse sales and growing Agamree revenue pushed results ahead of expectations and prompted management to raise its 2025 full year sales guidance. See our latest analysis for Catalyst Pharmaceuticals. That stronger outlook seems to be feeding into sentiment, with the stock showing a 15.8% 90 day share price return and a hefty 5 year total shareholder return above 500%. This suggests momentum is still building...

Earlier this month, Citigroup initiated coverage on Matador Resources with a new Buy rating, joining a field of 21 brokerage firms that collectively rate the company as Outperform. This fresh coverage underscores how Matador’s upstream oil and gas operations are drawing increased institutional attention within the broader energy extraction landscape. We’ll now explore how Citigroup’s new Buy rating may influence Matador’s existing investment narrative built around Delaware Basin...

In the past quarter, Credo Technology Group Holding Ltd reported a jump in revenue to US$268.03 million and moved from a small loss to US$82.64 million in net income, with earnings per share turning positive on both a basic and diluted basis. Alongside these stronger results, Credo issued higher third-quarter fiscal 2026 revenue guidance of US$335 million to US$345 million, signaling management’s confidence in continued demand for its high-speed connectivity solutions. With revenue and...

Johnson & Johnson (JNJ) keeps grinding higher, and with the stock up roughly 14% over the past 3 months and nearly 40% year to date, investors are asking what is driving the momentum. See our latest analysis for Johnson & Johnson. That surge has been backed by a solid 8% 1 month share price return and a powerful near 40% year to date share price gain, while a 5 year total shareholder return of about 56% shows momentum has been building, not fading, for long term holders. If J&J’s run has you...

Earlier this month, RadNet, Inc. filed a new omnibus shelf registration and closed a US$5.85 million shelf takedown covering 73,567 common shares for potential resale by existing stockholders, alongside registration capacity for preferred stock, debt securities, warrants, subscription rights, and units. While this move does not alter RadNet’s operating performance, it signals increased flexibility for existing holders to sell, which can influence how investors think about future share...

Key Insights Significantly high institutional ownership implies Kirloskar Pneumatic's stock price is sensitive to their...

China Galaxy Securities (SEHK:6881) has just wrapped up a RMB4 billion short term commercial paper issuance. This financing move sharpens its liquidity profile and gives it more flexibility on day to day funding needs. See our latest analysis for China Galaxy Securities. That push to shore up liquidity comes after a strong run, with a year to date share price return of about 60 percent and a three year total shareholder return above 200 percent, suggesting momentum is still broadly...

Genmab (CPSE:GMAB) is back in focus after new clinical data on EPKINLY showed strong efficacy signals in both follicular lymphoma and diffuse large B cell lymphoma, prompting investors to reassess the stock’s risk reward profile. See our latest analysis for Genmab. Those trial wins come on top of Genmab’s recent multi billion dollar debt raise to help fund its planned Merus acquisition. Investors seem to be warming up again, with a roughly 34 percent year to date share price return, but a...

Altria Group (MO) has quietly ground higher this year, up about 11% over the past year and roughly flat over the past month, as investors reassess its income and value appeal. See our latest analysis for Altria Group. With the share price now around $58.11, Altria’s modest year to date share price gain alongside a solid three and five year total shareholder return suggests steady income driven momentum rather than a fast growth story, as investors stay comfortable with its risk profile. If...

Gujarat Apollo Industries Limited ( NSE:GUJAPOLLO ) shareholders might be concerned after seeing the share price drop...

Industria de Diseño Textil (BME:ITX) just posted higher nine month sales and earnings, and the market reacted quickly as the stock climbed while the IBEX 35 pushed to fresh highs. See our latest analysis for Industria de Diseño Textil. The latest nine month numbers appear to have reignited interest in Industria de Diseño Textil, with a 26.38% 90 day share price return and a hefty 141.82% three year total shareholder return suggesting momentum is still building rather than fading. If this...

Wondering if Agilent Technologies is quietly becoming good value, or if the market is still pricing in too much optimism? Let us unpack what the current share price really implies, in plain language. The stock has slipped recently, down 5.1% over the last week and 2.9% over the last month, even though it is still up 6.8% year to date and roughly flat over the last year. Recent headlines have focused on Agilent sharpening its focus on high growth areas like diagnostics, life sciences tools,...

Incyte (INCY) has been quietly rewarding patient shareholders, with the stock up about 39% year to date despite a modest pullback over the past month. That mix of recent weakness and longer term strength creates an interesting entry point for investors watching this mid cap biotech name. See our latest analysis for Incyte. That recent 1 month share price return of negative 8.8 percent, including a sharp 1 day drop, looks more like a breather within a broader upswing, given the roughly 39...

If we want to find a stock that could multiply over the long term, what are the underlying trends we should look for...

If you are wondering whether Chewy is finally attractive at today’s price or still just a story stock that has run ahead of its fundamentals, this breakdown will help you frame the risk and reward in plain English. Chewy’s share price has been choppy, slipping about 0.5% over the last week but still up 2.7% over the past month and 12.1% over the last year, even after a tough 3-year and 5-year stretch with returns of around -23.3% and -58.2% respectively. Recent moves have come as investors...

Key Insights United Spirits' significant public companies ownership suggests that the key decisions are influenced by...

It's not a stretch to say that FP Corporation's ( TSE:7947 ) price-to-earnings (or "P/E") ratio of 14.4x right now...

With its stock down 17% over the past month, it is easy to disregard Bharat Seats (NSE:BHARATSE). However, a closer...

With its stock down 7.8% over the past month, it is easy to disregard Max Estates (NSE:MAXESTATES). However, stock...

MODEC, Inc.'s ( TSE:6269 ) dividend will be increasing from last year's payment of the same period to $80.00 on 30th of...